TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY

Irene Vita Brescia  ¹     Ilaria Lacavalla  ¹     Ilaria Ditonno  ¹     Silvia Mazzuoli  ²     Elisa Stasi  ³     Angela Maria D'Uggento  ³     Alfredo Di Leo  ³     Mariabeatrice Rita Daniela Principi  ^3    
1 Università degli Studi di Bari Aldo Moro, Bari, Italy
² Ospedale "Mons Raffaele Dimiccoli", Barletta, Italy
³ Ospedale "Vito Fazzi", Lecce, Italy

Topic
IBD

Session
The switch game: Optimal treatment modalities in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)